Patient characteristics associated with 17-alpha hydroxyprogesterone caproate use among a high-risk cohort

American Journal of Obstetrics and Gynecology

Volumn 214, Issue 4, 2016, Pages 536.e1-536.e5

  Turitz, Amy L ^a   Bastek, Jamie A ^a   Purisch, Stephanie E ^a   Elovitz, Michal A ^a   Levine, Lisa D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

17 alpha hydroxyprogesterone caproate; acceptance; barriers; prematurity prevention program; preterm birth

Indexed keywords

HYDROXYPROGESTERONE CAPROATE; GESTAGEN; HYDROXYPROGESTERONE;

ADULT; ARTICLE; BIRTH ORDER; BODY MASS; CERCLAGE; CERVICAL LENGTH MEASUREMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG USE; FEMALE; HEALTH INSURANCE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; OBESITY; PREGNANCY; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; RACE; SECOND TRIMESTER PREGNANCY; TERM BIRTH; FETUS DEATH; HIGH RISK PREGNANCY; PATIENT ATTITUDE; PENNSYLVANIA; PREMATURE BIRTH; RECURRENT DISEASE; STATISTICS AND NUMERICAL DATA; UTERINE CERVIX CERCLAGE;

17-ALPHA-HYDROXYPROGESTERONE; ADULT; CERCLAGE, CERVICAL; CROSS-SECTIONAL STUDIES; FEMALE; FETAL DEATH; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PENNSYLVANIA; PREGNANCY; PREGNANCY, HIGH-RISK; PREMATURE BIRTH; PROGESTINS; RECURRENCE;

EID: 84962090157     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2015.10.148     Document Type: Article

References (17)

1. B.E. Hamilton, J.A. Martin, and S.J. Ventura Births: preliminary data for 2012 Natl Vital Stat Rep 62 2013 1 20
2. C.Y. Spong Prediction and prevention of recurrent spontaneous preterm birth Obstet Gynecol 110 2007 405 415
3. P.J. Meis, M. Klebanoff, E. Thom, and et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate N Engl J Med 348 2003 2379 2385
4. American College of Obstetricians and Gynecologists Use of progesterone to reduce preterm birth. ACOG Committee opinion Obstet Gynecol 102 2003 1115 1116
5. Society for Maternal Fetal Medicine Publications Committee Use of progesterone to reduce preterm birth. ACOG Committee opinion no. 419 Obstet Gynecol 112 2008 963 965
6. Society for Maternal-Fetal Medicine Publications Committee, with assistance of Vincenzo Berghella Progesterone and preterm birth prevention: translating clinical trials data into clinical practice Am J Obstet Gynecol 206 2012 376 386
7. P.J. Meis 17 Hydroxyprogesterone for the prevention of preterm delivery Obstet Gynecol 105 2005 1128 1135
8. A. Ness, T. Dias, K. Damus, I. Burd, and V. Berghella Impact of the recent randomized trials on the use of progesterone to prevent preterm birth: a 2005 follow-up survey Am J Obstet Gynecol 195 2006 1174 1179
9. B.M. Sibai, N.B. Istwan, B. Palmer, and G.J. Stanziano Pregnancy outcomes of women receiving compounded 17 alpha-hydroxyprogesterone caproate for prophylactic prevention of preterm birth 2004 to 2011 Am J Perinatol 29 2012 635 642
10. A. Rebarber, N. Fox, C.K. Klauser, D. Saltzman, and A.S. Roman A national survey examining obstetrician perspectives on use of 17-alpha hydroxyprogesterone caproate post-US FDA approval Clin Drug Investig 33 2013 571 577
11. J.R. Petrini, W.M. Callaghan, M. Klebanoff, and et al. Estimated effect of 17 alpha-hydroxyprogesterone caproate on preterm birth in the United States Obstet Gynecol 105 2005 267 272
12. J. Owen, G. Hankins, J.D. Iams, and et al. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length Am J Obstet Gynecol 201 2009 375.e1 375.e8
13. J. Owen, N. Yost, V. Berghella, and et al. Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth JAMA 286 2001 1340 1348
14. S.S. Hassan, R. Roberto, S.M. Berry, and et al. Patients with an ultrasonographic cervical length ≤15 mm have nearly a 50% risk of early spontaneous preterm delivery Am J Obstet Gynecol 182 2000 1458 1467
15. J. Timofeev, J. Singh, N. Istwan, D. Rhea, and R.W. Driggers Spontaneous preterm birth in African-American and Caucasian women receiving 17α-hydroxyprogesterone caproate Am J Perinatol 31 2014 55 60
16. S.N. Caritis, S. Sharma, R. Venkataramanan, and et al. Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation Am J Obstet Gynecol 205 2011 40.e1 40.e8
17. T.A. Manuck, Y. Lai, P.J. Meis, and et al. Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate Am J Obstet Gynecol 205 2011 135.e1 135.e9